143 related articles for article (PubMed ID: 28727139)
1. Effect of solvent/detergent-treated pooled plasma on fibrinolysis in reconstituted whole blood.
Saadah NH; van der Meer PF; Brinkman HJM; de Korte D; Bontekoe IJ; Korsten HH; Middelburg RA; van der Bom JG; Schipperus MR
Transfusion; 2017 Oct; 57(10):2381-2389. PubMed ID: 28727139
[TBL] [Abstract][Full Text] [Related]
2. Increased urokinase and consumption of α
Longstaff C; Locke M
J Thromb Haemost; 2019 Jan; 17(1):195-205. PubMed ID: 30451372
[TBL] [Abstract][Full Text] [Related]
3. An in vitro study of the effects of t-PA and tranexamic acid on whole blood coagulation and fibrinolysis.
Godier A; Parmar K; Manandhar K; Hunt BJ
J Clin Pathol; 2017 Feb; 70(2):154-161. PubMed ID: 27445340
[TBL] [Abstract][Full Text] [Related]
4. Enhanced thrombin generation and reduced intact protein S in processed solvent detergent plasma.
Pitkänen H; Jouppila A; Mowinckel MC; Lemponen M; Patiwael S; Sandset PM; Lassila R; Brinkman HJ
Thromb Res; 2015 Jan; 135(1):167-74. PubMed ID: 25466844
[TBL] [Abstract][Full Text] [Related]
5. Carbon monoxide releasing molecule-2 enhances α2-antiplasmin activity.
Malayaman SN; Cohen JB; Machovec KA; Bernhardt BE; Arkebauer MR; Nielsen VG
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):345-8. PubMed ID: 21330914
[TBL] [Abstract][Full Text] [Related]
6. Clot lysis time in platelet-rich plasma: method assessment, comparison with assays in platelet-free and platelet-poor plasmas, and response to tranexamic acid.
Panes O; Padilla O; Matus V; Sáez CG; Berkovits A; Pereira J; Mezzano D
Platelets; 2012; 23(1):36-44. PubMed ID: 21787173
[TBL] [Abstract][Full Text] [Related]
7. Influence of resuscitation fluids, fresh frozen plasma and antifibrinolytics on fibrinolysis in a thrombelastography-based, in-vitro, whole-blood model.
Kostousov V; Wang YW; Cotton BA; Wade CE; Holcomb JB; Matijevic N
Blood Coagul Fibrinolysis; 2013 Jul; 24(5):489-97. PubMed ID: 23406662
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of tranexamic acid in healthy dogs and assessment of its antifibrinolytic properties in canine blood.
Osekavage KE; Brainard BM; Lane SL; Almoslem M; Arnold RD; Koenig A
Am J Vet Res; 2018 Oct; 79(10):1057-1063. PubMed ID: 30256146
[TBL] [Abstract][Full Text] [Related]
9. Effects of solvent/detergent-treated plasma and fresh-frozen plasma on haemostasis and fibrinolysis in complex coagulopathy following open-heart surgery.
Haubelt H; Blome M; Kiessling AH; Isgro F; Bach J; Saggau W; Hellstern P
Vox Sang; 2002 Jan; 82(1):9-14. PubMed ID: 11856461
[TBL] [Abstract][Full Text] [Related]
10. Hemostatic Therapy Using Tranexamic Acid and Coagulation Factor Concentrates in a Model of Traumatic Liver Injury.
Zentai C; van der Meijden PE; Braunschweig T; Hueck N; Honickel M; Spronk HM; Rossaint R; Grottke O
Anesth Analg; 2016 Jul; 123(1):38-48. PubMed ID: 27192476
[TBL] [Abstract][Full Text] [Related]
11. The antifibrinolytic effects of carbon monoxide-releasing molecule-2 are fibrin and alpha2-antiplasmin dependent.
Nielsen VG
Blood Coagul Fibrinolysis; 2010 Sep; 21(6):584-7. PubMed ID: 20683324
[TBL] [Abstract][Full Text] [Related]
12. Stabilization of fibrin clots by activated prothrombin complex concentrate and tranexamic acid in FVIII inhibitor plasma.
Dai L; Bevan D; Rangarajan S; Sørensen B; Mitchell M
Haemophilia; 2011 Sep; 17(5):e944-8. PubMed ID: 21371192
[TBL] [Abstract][Full Text] [Related]
13. Solvent/detergent-treated plasma has decreased antitrypsin activity and absent antiplasmin activity.
Mast AE; Stadanlick JE; Lockett JM; Dietzen DJ
Blood; 1999 Dec; 94(11):3922-7. PubMed ID: 10572109
[TBL] [Abstract][Full Text] [Related]
14. Hydroxyethyl starch enhances fibrinolysis in human plasma by diminishing alpha2-antiplasmin-plasmin interactions.
Nielsen VG
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):647-56. PubMed ID: 17890952
[TBL] [Abstract][Full Text] [Related]
15. Fibrinolysis during liver transplantation is enhanced by using solvent/detergent virus-inactivated plasma (ESDEP).
de Jonge J; Groenland TH; Metselaar HJ; IJzermans JN; van Vliet HH; Visser L; Tilanus HW
Anesth Analg; 2002 May; 94(5):1127-31, table of contents. PubMed ID: 11973173
[TBL] [Abstract][Full Text] [Related]
16. The effect of solvent/detergent-treated plasma on stored platelet concentrates.
Tocci LJ; Napychank PA; Cable RG; Snyder EL
Transfusion; 1993 Feb; 33(2):145-9. PubMed ID: 8430454
[TBL] [Abstract][Full Text] [Related]
17. Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: A prospective, controlled, in-vitro study.
Rozen L; Faraoni D; Sanchez Torres C; Willems A; Noubouossie DC; Barglazan D; Van der Linden P; Demulder A
Eur J Anaesthesiol; 2015 Dec; 32(12):844-50. PubMed ID: 26258658
[TBL] [Abstract][Full Text] [Related]
18. Impaired activation of the fibrinolytic system in children with Henoch-Schönlein purpura: beneficial effect of hydrocortisone plus Sigma-aminocaproic acid therapy on disappearance rate of cutaneous vasculitis and fibrinolysis.
Prandota J; Pankow-Prandota L; Kotecki L
Am J Ther; 2001; 8(1):11-9. PubMed ID: 11304653
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of primary hyperfibrinolysis and in vitro investigation of the inhibitory effects of tranexamic acid in a group of dogs with sarcomas - A pilot study.
Langhorn R; Poulsen MK; Heidemann PL; Bochsen L; Ritz C; Kristensen AT; Nielsen LN
Res Vet Sci; 2021 May; 136():472-477. PubMed ID: 33838456
[TBL] [Abstract][Full Text] [Related]
20. Factor XIII and tranexamic acid but not recombinant factor VIIa attenuate tissue plasminogen activator-induced hyperfibrinolysis in human whole blood.
Dirkmann D; Görlinger K; Gisbertz C; Dusse F; Peters J
Anesth Analg; 2012 Jun; 114(6):1182-8. PubMed ID: 22104068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
